Alzheimer's Disease Neuroimaging Initiative (ADNI) is a multisite study that aims to improve clinical trials for the prevention and treatment of Alzheimer’s disease (AD).[1] This cooperative study combines expertise and funding from the private and public sector to study subjects with AD, as well as those who may develop AD and controls with no signs of cognitive impairment.[2] Researchers at 63 sites in the US and Canada track the progression of AD in the human brain with neuroimaging, biochemical, and genetic biological markers.[2][3] This knowledge helps to find better clinical trials for the prevention and treatment of AD. ADNI has made a global impact,[4] firstly by developing a set of standardized protocols to allow the comparison of results from multiple centers,[4] and secondly by its data-sharing policy which makes available all at the data without embargo to qualified researchers worldwide.[5] To date, over 1000 scientific publications have used ADNI data.[6] A number of oth
16 PAPERS • 2 BENCHMARKS
CHAOS challenge aims the segmentation of abdominal organs (liver, kidneys and spleen) from CT and MRI data. ONsite section of the CHAOS was held in The IEEE International Symposium on Biomedical Imaging (ISBI) on April 11, 2019, Venice, ITALY. Online submissions are still welcome!
8 PAPERS • NO BENCHMARKS YET
Accurate lesion segmentation is critical in stroke rehabilitation research for the quantification of lesion burden and accurate image processing. Current automated lesion segmentation methods for T1-weighted (T1w) MRIs, commonly used in rehabilitation research, lack accuracy and reliability. Manual segmentation remains the gold standard, but it is time-consuming, subjective, and requires significant neuroanatomical expertise. However, many methods developed with ATLAS v1.2 report low accuracy, are not publicly accessible or are improperly validated, limiting their utility to the field. Here we present ATLAS v2.0 (N=1271), a larger dataset of T1w stroke MRIs and manually segmented lesion masks that includes training (public. n=655), test (masks hidden, n=300), and generalizability (completely hidden, n=316) data. Algorithm development using this larger sample should lead to more robust solutions, and the hidden test and generalizability datasets allow for unbiased performance evaluation
6 PAPERS • 1 BENCHMARK
Breast MRI scans of 922 cancer patients from Duke University, with tumor bounding box annotations, clinical, imaging, and many other features, and more.
5 PAPERS • NO BENCHMARKS YET
Cancer in the region of the head and neck (HaN) is one of the most prominent cancers, for which radiotherapy represents an important treatment modality that aims to deliver a high radiation dose to the targeted cancerous cells while sparing the nearby healthy organs-at-risk (OARs). A precise three-dimensional spatial description, i.e. segmentation, of the target volumes as well as OARs is required for optimal radiation dose distribution calculation, which is primarily performed using computed tomography (CT) images. However, the HaN region contains many OARs that are poorly visible in CT, but better visible in magnetic resonance (MR) images. Although attempts have been made towards the segmentation of OARs from MR images, so far there has been no evaluation of the impact the combined analysis of CT and MR images has on the segmentation of OARs in the HaN region. The Head and Neck Organ-at-Risk Multi-Modal Segmentation Challenge aims to promote the development of new and application of
The Sunnybrook Cardiac Data (SCD), also known as the 2009 Cardiac MR Left Ventricle Segmentation Challenge data, consist of 45 cine-MRI images from a mixed of patients and pathologies: healthy, hypertrophy, heart failure with infarction and heart failure without infarction. Subset of this data set was first used in the automated myocardium segmentation challenge from short-axis MRI, held by a MICCAI workshop in 2009. The whole complete data set is now available in the CAP database with public domain license.
Autism spectrum disorder (ASD) is characterized by qualitative impairment in social reciprocity, and by repetitive, restricted, and stereotyped behaviors/interests. Previously considered rare, ASD is now recognized to occur in more than 1% of children. Despite continuing research advances, their pace and clinical impact have not kept up with the urgency to identify ways of determining the diagnosis at earlier ages, selecting optimal treatments, and predicting outcomes. For the most part this is due to the complexity and heterogeneity of ASD. To face these challenges, large-scale samples are essential, but single laboratories cannot obtain sufficiently large datasets to reveal the brain mechanisms underlying ASD. In response, the Autism Brain Imaging Data Exchange (ABIDE) initiative has aggregated functional and structural brain imaging data collected from laboratories around the world to accelerate our understanding of the neural bases of autism. With the ultimate goal of facilitating
3 PAPERS • NO BENCHMARKS YET
This collection includes datasets from 20 subjects with primary newly diagnosed glioblastoma who were treated with surgery and standard concomitant chemo-radiation therapy (CRT) followed by adjuvant chemotherapy. Two MRI exams are included for each patient: within 90 days following CRT completion and at progression (determined clinically, and based on a combination of clinical performance and/or imaging findings, and punctuated by a change in treatment or intervention). All image sets are in DICOM format and contain T1w (pre and post-contrast agent), FLAIR, T2w, ADC, normalized cerebral blood flow, normalized relative cerebral blood volume, standardized relative cerebral blood volume, and binary tumor masks (generated using T1w images). The perfusion images were generated from dynamic susceptibility contrast (GRE-EPI DSC) imaging following a preload of contrast agent. All of the series are co-registered with the T1+C images. The intent of this dataset is for assessing deep learnin
2 PAPERS • NO BENCHMARKS YET
This mouse cerebellar atlas can be used for mouse cerebellar morphometry.
Several datasets are fostering innovation in higher-level functions for everyone, everywhere. By providing this repository, we hope to encourage the research community to focus on hard problems. In this repository, we present our medical imaging DICOM files of patients from our User Tests and Analysis 4 (UTA4) study. Here, we provide a dataset of the used medical images during the UTA4 tasks. This repository and respective dataset should be paired with the dataset-uta4-rates repository dataset. Work and results are published on a top Human-Computer Interaction (HCI) conference named AVI 2020 (page). Results were analyzed and interpreted on our Statistical Analysis charts. The user tests were made in clinical institutions, where clinicians diagnose several patients for a Single-Modality vs Multi-Modality comparison. For example, in these tests, we used both prototype-single-modality and prototype-multi-modality repositories for the comparison. On the same hand, the hereby dataset repres
1 PAPER • 1 BENCHMARK
Click to add a brief description of the dataset (Markdown and LaTeX enabled).
1 PAPER • NO BENCHMARKS YET
Mouse Brain MRI atlas (both in-vivo and ex-vivo) (repository relocated from the original webpage)